SCHEMBL9461102

SCHEMBL9461102

OCCC=Cc1ccc(Cl)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 1/20 0.47
▸ AHR P35869 1/20 0.45
▸ GRIK1 P39086 1/20 0.42
▸ GRIK2 Q13002 1/20 0.42
▸ GRIK3 Q13003 1/20 0.42
▸ DRD2 P14416 2/20 0.41
▸ ALOX5 P09917 1/20 0.41
▸ PTGS1 P23219 1/20 0.41
▸ PTGS2 P35354 1/20 0.41
▸ KCNH2 Q12809 2/20 0.41
▸ FBP1 P09467 1/20 0.39
▸ HSD17B10 Q99714 1/20 0.39
▸ HDAC2 Q92769 2/20 0.39
▸ MAOB P27338 1/20 0.39
▸ HDAC3 O15379 1/20 0.39
▸ HDAC4 P56524 1/20 0.39
▸ HDAC1 Q13547 1/20 0.39
▸ HDAC7 Q8WUI4 1/20 0.39
▸ HDAC10 Q969S8 1/20 0.39
▸ HDAC11 Q96DB2 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9461100 1.00 CYP1A2 (0.47) CYP1A2AHRGRIK1GRIK2GRIK3
SCHEMBL79528 0.82 ALDH1A1 (0.52) CYP1A2AHRGRIK1GRIK2GRIK3
SCHEMBL79527 0.82 ALDH1A1 (0.52) CYP1A2AHRGRIK1GRIK2GRIK3
SCHEMBL9661520 0.80 AHR (0.46) CYP1A2AHRGRIK1GRIK2GRIK3
SCHEMBL9661512 0.80 AHR (0.46) CYP1A2AHRGRIK1GRIK2GRIK3
SCHEMBL5682382 0.78 AHR (0.45) CYP1A2AHRGRIK1GRIK2GRIK3
SCHEMBL2089769 0.78 CYP1A2 (0.47) CYP1A2AHRGRIK1GRIK2GRIK3
SCHEMBL2089767 0.78 CYP1A2 (0.47) CYP1A2AHRGRIK1GRIK2GRIK3
SCHEMBL8325205 0.78 AHR (0.45) CYP1A2AHRGRIK1GRIK2GRIK3
SCHEMBL13824133 0.78 KCNH2 (0.53) CYP1A2AHRGRIK1GRIK2GRIK3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115772063-A Preparation process and method of chloro (bromo) styrene 中国科学院大连化学物理研究所 2023-03-10 — — CN disclosed
EP-3768260-A1 OXADIAZOLE TRANSIENT RECEPTOR POTENTIAL CHANNEL INHIBITORS F. Hoffmann-La Roche AG (CH) 2021-01-27 — — EP disclosed
WO-2019182925-A1 OXADIAZOLE TRANSIENT RECEPTOR POTENTIAL CHANNEL INHIBITORS GENENTECH, INC. (US) 2019-09-26 — — WO disclosed
EP-3262026-A1 NEW TRIFLUOROMETHYLPROPANAMIDE DERIVATIVES F. Hoffmann-La Roche AG (CH) 2018-01-03 — — EP disclosed
EP-3116880-A1 PYRIDIN-3-YL ACETIC ACID MACROCYCLES AS INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION VIIV Healthcare UK (No.5) Limited (GB) 2017-01-18 — — EP disclosed
WO-2016135070-A1 NEW TRIFLUOROMETHYLPROPANAMIDE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2016-09-01 — — WO disclosed
WO-2015127003-A1 PYRIDIN-3-YL ACETIC ACID MACROCYCLES AS INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION BRISTOL-MYERS SQUIBB COMPANY (US) 2015-08-27 — — WO disclosed
CN-104450852-A Method for preparing homoallylic alcohol compound UNIV NINGXIA 2015-03-25 — — CN disclosed
US-5232916-A Inhibitors of leukotriene synthesis MERCK FROSST CANADA, INC. (CA) 1993-08-03 — — US disclosed
US-5102881-A Leukotriene biosynthesis inhibitor MERCK FROSST CANADA, INC. (CA) 1992-04-07 — — US disclosed
EP-0349062-A1 Quinoline ether alkanoic acid MERCK FROSST CANADA INC. (CA) 1990-01-03 — — EP disclosed
Send feedback